Status:
NOT_YET_RECRUITING
Development and Characterization of Functional Assays for the Analysis of Inflammation Signaling Pathways
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Autoinflammatory Disease
Eligibility:
All Genders
4+ years
Brief Summary
Auto-inflammatory diseases are part of a heterogeneous group of illnesses manifested by an inflammatory reaction in its initial phase (innate immunity) that is activated inappropriately: either becaus...
Eligibility Criteria
Inclusion
- For adults :
- Inclusion Criteria :
- Major patient
- Patient with a rare autoinflammatory disease
- Patient who has given his or her consent to participate in research
- Exclusion Criteria :
- Patient under legal protection or safeguard of justice or any other protective measure (guardianship, curatorship)
- Patient with known infection with hepatitis B or C virus or human immunodeficiency virus (HIV)
- For Kids :
- Inclusion Criteria :
- Minor patients (between 4 and 17 years of age)
- Patient with a rare autoinflammatory disease.
- No additional genetic research will be carried out as part of the project.
- Parents/legal guardians of the child who have given their non-objection to participate in the research.
- Exclusion Criteria :
- Patient under legal protection or safeguard of justice or any other protective measure (guardianship, curators)
- Patient with known infection with hepatitis B or C virus or human immunodeficiency virus (HIV)
Exclusion
Key Trial Info
Start Date :
October 15 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 15 2029
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06971289
Start Date
October 15 2025
End Date
October 15 2029
Last Update
September 18 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.